Suppl Fig S1 from Non-BRCA DNA Damage Repair Gene Alterations and Response to the PARP Inhibitor Rucaparib in Metastatic Castration-Resistant Prostate Cancer: Analysis From the Phase II TRITON2 Study

Authors:
  • WAWassim Abida
    Wassim Abida
  • DCDavid Campbell
    David Campbell
  • APAkash Patnaik
    Akash Patnaik
  • JSJeremy D. Shapiro
    Jeremy D. Shapiro
  • BSBrieuc Sautois
    Brieuc Sautois
  • EVEric G. Voog
    Eric G. Voog
  • RMRay McDermott
    Ray McDermott
  • FRFrancesco Ricci
    Francesco Ricci
  • JRJulie Rowe
    Julie Rowe
  • JZJingsong Zhang
    Jingsong Zhang

Abstract
Supplementary Figure S1. Incidence of gene alteration types for patients from TRITON2 with non-BRCA DDR gene alterations.